Jenny K.W. Lam

The involvement of microtubules and actin filaments in the intracellular transport of non-viral gene delivery system.

Pulmonary delivery of therapeutic siRNA.

Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.

Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.

Western Blot Evaluation of siRNA Delivery by pH-Responsive Peptides.

Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.

Oral transmucosal drug delivery for pediatric use.

Manipulating the pH response of 2,3-diaminopropionic acid rich peptides to mediate highly effective gene silencing with low-toxicity.

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis.

Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.

Oleanolic Acid Loaded PEGylated PLA and PLGA Nanoparticles with Enhanced Cytotoxic Activity against Cancer Cells.

Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.

Dry Powder Formulation of Plasmid DNA and siRNA for Inhalation.

siRNA Versus miRNA as Therapeutics for Gene Silencing.

Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis.

Incorporation of a Nuclear Localization Signal in pH Responsive LAH4-L1 Peptide Enhances Transfection and Nuclear Uptake of Plasmid DNA.

Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside.

Steroidogenic effect of Erxian decoction for relieving menopause via the p-Akt/PKB pathway in vitro and in vivo.

Water-in-Oil Microemulsions for Protein Delivery: Loading Optimization and Stability.

Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.

From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.

Synthesis, Structure⁻Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers.

Rifampin- or Capreomycin-Induced Remodeling of the Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides.

Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.

Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.

Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.

High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin.

Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery.

Modification of KL4 Peptide Revealed the Importance of Alpha-Helical Structure for Efficient Small Interfering RNA Delivery.

Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.